Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Pharma firms pledge vaccine support for developing countries

January 27, 2015 Manufacturing and Production, Research and Development, Sales and Marketing GAVI, GSK, Janssen, Médecins Sans Frontières, Pfizer, Vaccine

Several pharma firms have announced commitments to help Gavi, the global vaccine alliance, to increase immunisation of children in developing …
News

Bayer launches major new stroke trial

January 27, 2015 Research and Development, Sales and Marketing Bayer, Canadian Stroke Prevention Intervention Network, Population Health Research Institute, Xarelto, rivaroxaban, stroke

Bayer is enrolling more than 7,000 people in a trial to test whether its blood-thinning drug Xarelto can successfully prevent …
News

ABPI appoints Amgen director to innovation role

January 27, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Amgen, Bina Rawal, Virginia Acha

The Association of the British Pharmaceutical Industry (ABPI) has named Dr Virginia Acha as its new executive director of Research …
Appointment

Actavis buys generics firm for £306 million

January 26, 2015 Manufacturing and Production, Sales and Marketing Actavis, Allergan, Auden McKenzie, generics

Actavis is buying UK-based development and marketing firm Auden McKenzie in a deal worth up to £306 million. The move …
News

New drug added to generic Sovaldi licensing

January 26, 2015 Manufacturing and Production, Sales and Marketing Gilead, HCV, hepatitis C, sofosbuvir, sovaldi

Gilead has expanded the licensing of generic versions of its blockbuster hepatitis C treatment Sovaldi to include a new experimental …
News

Shire lifted by rare disease approvals

January 26, 2015 Sales and Marketing HGT-2310, Hunter syndrome, SHP609, Shire, fast track, idursulfase-IT, rare disease

Shire’s investigational drug for a rare neurological disease has been accepted into the FDA’s fast-track approval process. The drug, SHP609, …
News

NICE recommends Bayer heart attack drug

January 26, 2015 Sales and Marketing ACS, Bayer, J&J, JJ, NICE, Xarelto, q4, rivaroxaban

NICE has recommended Xarelto in final draft guidance as an option for preventing blood clots in people who have had …
News

Novartis earns EMA and FDA nods for Jakavi and Bexsero

January 26, 2015 Sales and Marketing Bexsero, Cancer, EU, FDA, Jakavi, Novartis, US, meningitis, ruxolitinib

Novartis has secured the regulatory go-ahead for two of its drugs, after the EMA recommended Jakavi for a rare blood …
News

Working Life: NHS England pharma officer Dr Bruce Warner

January 26, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS England, Working Life, bruce warner, pharma officer

 How did you find your way into your current role? I have had a very eclectic career for a pharmacist …
Feature

Cipher appoints vice president and promotes two

January 26, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Linda Angaritis, Peter Weiler, cipher, lynne bulgar

Cipher Pharmaceuticals has appointed Lynne Bulger as vice president of its medical and clinical affairs whilst also promoting Peter Weiler …
Appointment

GSK launches Ebola Phase III trial in Liberia

January 23, 2015 Research and Development, Sales and Marketing Africa, Ebola, GSK, US National Institutes of Health, WHO, Wellcome Trust, liberia, newlink

A shipment of GSK’s potential vaccine against the Ebola virus disease is on its way to Liberia ready to be …
News

Needle-free device shows potential in diabetes

January 23, 2015 Medical Communications, Sales and Marketing Cygnus, University of California, diabetes, tattoo

A ‘tattoo-like’ ultra-thin sensor that sits on the skin has been developed that could help patients monitor their blood glucose …
News

Immune Pharmaceuticals appoints three

January 23, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Immune Pharmaceuticals, cameron durrant, elliot maza, gad berdugo

US antibody development firm Immune Pharmaceuticals has appointed Gad Berdugo (pictured) as its executive VP and chief financial officer, and …
Appointment

FDA to start regulating health wearables

January 22, 2015 Medical Communications, Sales and Marketing Apple, FDA, Samsung, digital, wearables

Any firms making exaggerated health claims of wearable devices face marketplace disappointment following new FDA guidelines. The FDA has released …
News

Sanofi Gaucher drug approved in Europe

January 22, 2015 Sales and Marketing Cerdelga, Cerezyme, Gaucher, Sanofi, eliglustat, imiglucerase

The European Commission has approved Sanofi-owned Genzyme’s Cerdelga for the treatment of Gaucher disease Type 1.Designed for a condition that …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026